Coty (COTY) Q1 2026 earnings review
Weak Results and Gucci Drama Obscure Glimmer of a Turnaround
Coty reported another challenging quarter with LFL sales falling 8%, marking the fourth consecutive period of decline. Both the Prestige (-6% LFL) and Consumer Beauty (-11% LFL) segments contracted, with Consumer Beauty's profitability nearly wiped out (0.3% adj. operating margin). However, the narrative was dominated by the ongoing dispute over the Gucci license, which was the focus of the earnings call. Management is framing the current weakness as a deliberate, temporary 'cleanup' of retailer inventories, guiding for an improved rate of decline in Q2 (-3% to -5% LFL) and a return to growth in the second half of FY26. While the guidance suggests the worst may be over, the severe underlying weakness and major strategic distractions create significant execution risk for the planned recovery.
🐂 Bull Case
Management's guidance for Q2 implies a significant deceleration in the rate of sales decline, with a return to growth forecast for H2 FY26. This suggests the strategic inventory reduction is nearing its end and comps are becoming much easier.
Early results from the new BOSS Bottled Beyond launch and the multi-brand push into high-margin fragrance mists are positive. This demonstrates an ability to innovate within their core strength to create new growth avenues.
🐻 Bear Case
The Consumer Beauty segment is in freefall. LFL sales dropped 11% and the adjusted operating margin compressed from 4.3% to a mere 0.3%, indicating the division is barely profitable and a significant drag on the company.
The entire earnings call focused on the dispute with Kering over the Gucci license. This is a massive management distraction and creates a future revenue and profit hole that the company must strategically fill.
⚖️ Verdict: 🔴
Bearish. The current operational performance is extremely weak, particularly the near-total erosion of profitability in the Consumer Beauty segment. While the improved guidance offers a glimmer of hope, the recovery is entirely forward-looking and dependent on flawless execution. The significant distraction and future financial impact of the Gucci license dispute add a layer of risk that overshadows the potential turnaround story.
Key Themes
Consumer Beauty Profitability Evaporates
The Consumer Beauty segment showed alarming deterioration. While the narrative focuses on a 'performance improvement plan', the data reveals a collapse. LFL sales fell 11%, but more critically, the adjusted operating margin cratered to just 0.3% from 4.3% a year ago, with adjusted operating income down 94% to $1.5 million. This indicates a near-complete erosion of profitability in a segment representing 32% of company revenue, making it a major drag on overall results.
Gucci License Dispute Creates Major Overhang
The future of the Gucci license, which accounts for up to 10% of sales, dominated the earnings call. CEO Sue Nabi confirmed the company will 'defend our rights until the last day' but is open to a value-creating deal for an early exit. This protracted and public dispute is a significant distraction for management and creates uncertainty around a key brand, while signaling a substantial future revenue and profit gap that must be filled by other portfolio brands.
Innovation Focus on High-Growth Fragrance Adjacencies
Coty is pushing aggressively into new fragrance formats to drive growth. The multi-brand expansion into fragrance mists (Kylie Cosmetics, Calvin Klein, philosophy) is successfully attracting younger Gen Z consumers with products that management claims are incremental and carry prestige-level gross margins. This is complemented by the launch of ultra-premium collections (growing 17% in Q1) and new blockbuster fragrances like BOSS Bottled Beyond, which is performing strongly in Europe.
Retailer Destocking Continues to Pressure Sales
A key driver of the 8% LFL sales decline is the ongoing effort to 'rightsize retailer inventory levels'. This was a major factor in the weak Q4 FY25 results and continued through Q1 FY26. While management expects this headwind to abate in H2 FY26, it is currently depressing reported results and masking true underlying consumer demand (sell-out).
Strategic Review of Mass Cosmetics and Brazil
The company has initiated a strategic review of its mass color cosmetics business (~$1.2B in FY25 sales) and its distinct Brazil business (~$400M in FY25 sales). A new president, Gordon von Bretten, has been appointed to lead the Consumer Beauty turnaround. Management indicated that a conclusion on the profitable Brazil business could come sooner than for the more challenged color cosmetics portfolio, signaling potential divestitures.
Tariffs Impacting Gross Margin
External pressures are becoming more visible in the P&L. Management noted that the 100 basis point decline in gross margin included a 40 basis point headwind from tariffs. This confirms that trade policy is having a tangible negative impact on profitability, a headwind previously flagged in Q4 FY25.
Other KPIs
Decelerating. The sales decline was broad-based across all geographic segments. The 9% LFL decline in EMEA, the company's largest region, was particularly weak and driven by softness in the Consumer Beauty color cosmetics business. The Americas decline was impacted by retailer inventory rightsizing.
Stable. Q1 FCF of $11.2M was an improvement from a $7.9M outflow in the prior year. However, management has guided for over $350M in free cash flow for the first half of FY26, implying a very strong cash generation of over $340M is expected in Q2.
Stable. Leverage increased slightly from 3.5x at the end of Q4 FY25 due to lower TTM adjusted EBITDA. The company remains focused on deleveraging towards an investment grade profile and is actively pursuing the monetization of its Wella stake.
Guidance
Decelerating decline. Guidance to the 'more favorable end' of this range (i.e., closer to -3%) implies a significant improvement from the -8% LFL decline in Q1. This signals management believes the worst of the retailer destocking impact is passing.
Reversing. The company expects to return to positive LFL sales and adjusted EBITDA growth in the second half of the fiscal year. This is driven by the combination of new product launches and lapping the very weak performance from H2 FY25 (Q3 LFL -3%, Q4 LFL -9%).
Decelerating. This target compares to $1.08 billion delivered in FY25, implying a full-year decline of approximately 7.5%. Given the guided decline in H1, this forecast relies on a very strong profit recovery in the second half of the year.